| United States Regulations -> FDA (Food and Drug Administration) -> 21 CFR 177.2600 |
 |
|
| |
| United States Regulations -> USP (U.S. Pharmacopeia) -> 90- Day implant, exceeds USP Class VI |
 |
|
| |
| United States Regulations -> USP (U.S. Pharmacopeia) -> Class V |
 |
|
| |
| United States Regulations -> USP (U.S. Pharmacopeia) -> Class VI |
 |
|
| |
| Europe Regulations -> EP (European Pharmacopeia) -> Monograph 3.1.9. Closures and Tubing: Tested for Substances Soluble in Hexane |
 |
|
| |
| Europe Regulations -> EP (European Pharmacopeia) -> Monograph 3.1.9. Closures and Tubing: Tested for Volatile Matter |
 |
|
| |
| United States Regulations -> USP (U.S. Pharmacopeia) -> Pyrogenicity |
 |
|
| |
| United States Regulations -> USP (U.S. Pharmacopeia) -> Tested for Cytotoxicity |
 |
|
| |
| United States Regulations -> USP (U.S. Pharmacopeia) -> Tested for Hemolysis |
 |
|
| |
| United States Regulations -> USP (U.S. Pharmacopeia) -> Tested for Mutagenicity / Genotoxicity |
 |
|
| |
| United States Regulations -> USP (U.S. Pharmacopeia) -> Tested for Skin Sensitization |
 |
|